Targeting Lifestyle to Improve Colorectal Cancer Screening

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-56
SponsorNorwegian Institute of Public Health

About this trial

The goal of this study is to learn whether receiving personalized, digital lifestyle advice during colorectal cancer screening leeds to changes in lifestyle over a two-year follow-up period. Changes will be measured using a composite score including diet, alcohol consumption, physical activity, body mass index and smoking habits. The main questions it aims to answer are:

* Do participants who receive short, personalized digital feedback on their lifestyle - either once or through repeated rounds -change their lifestyle during the two-year study period, compared to those who do not receive any feedback? * Does the inclusion of additional contact, such as telephone consultation with healthcare providers, result in further lifestyle changes?

Researchers will compare three groups which receive digital feedback at different intensities and a control group which does not get any feedback to see if lifestyle changes differ between the groups.

Participants in four different groups will fill in a digital diet and lifestyle questionnaire at the start of the study and 2-4 times after this during the following 2 years.

* Participants in three of the groups will receive a short digital feedback report on their lifestyle related to health recommendations after each completion of the questionnaire. * One of these groups will also be offered to go through the feedback report together with a healthcare provider in a telephone call. * This group will also receive invitations to motivational webinars every half year during the 2-year study period. The topics in the webinars address cancer preventive lifestyle.

A secondary goal of the study is to understand whether the invitation to fill in the diet and lifestyle questionnaire affects participation in colorectal cancer screening. Therefore, a fifth group of individuals invited to colorectal cancer screening but not to be invited to fill in the questionnaire will be included for extra comparison. Participation in colorectal cancer screening will be compared between this group and the four groups that are additionally invited to complete the questionnaire.

Another secondary goal is to learn which groups in the society consent to the current study. Therefore, sociodemographic characteristics will be compared between the invited individuals who consent and those who do not consent to the study.

Eligibility criteria

Qualifiers

Invited to the first round of immunochemical faecal blood testing in the national colorectal cancer screening program via a digital platform.

Disqualifiers

Not invited to the national colorectal cancer screening program.

Trial design

Treatments tested in this trial

  • Digikost report baseline only
  • Digikost report intensive with individual counselling and webinars
  • Digikost report intensive

Treatment groups

16,000 Participants
are divided into 5 treatment groups

Sponsors and collaborators

Norwegian Institute of Public Health

Lead sponsor

University of Oslo

Collaborator

Norwegian Cancer Society

Collaborator